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Abstract
As we conclude another year (2015), Volume 2 completed,
we are pleased with the number of quality published
manuscripts. We are also excited to announce Nanobiome‐
dicine has been indexed in DOAJ (Directory of Open Access
Journals) (https://doaj.org/toc/1849-5435)! This was in part
attributed with the help of our Special Editor, Dr. Barbara
Smith, who spearheaded manuscripts highlighting inno‐
vative results that impacted the global health spectrum
implementing new methods for disease diagnosis, includ‐
ing technological and product development for enhanced
point-of-care and personalized health care. Dr. Smith
undertook this endeavor as she transitioned from a post-
doc position (from George Whitesides’ lab at Harvard
University) to a faculty position at Arizona State, getting
acclimated and setting up her laboratory. We want to thank
Dr. Smith for her time and commitment to our journal. It’s
worth noting, we had a high number of submissions
throughout the year, however, the expectations of the
manuscripts not published fell short due to our review
process, indicating the emphasis of publishing high quality
manuscripts. We thank all the reviewers for their time and
feedback.
Nanobiomedicine in Numbers
By the end of its 2nd volume, the journal's articles have been
viewed more than 40,000 times and downloaded more than
6,000 times in total. The top 3 countries by number of
submissions were USA, Czech Republic and Spain, while
the most frequent readers were from India, Austria and
USA.Based on the ratio between the number of views and
downloads, the most popular research paper published in
the journal for the year 2015 is the following:
ELISA-like Analysis of Cisplatinated DNA Using Magnetic
Separation- by Kristyna Smerkova, Marcela Vlcnovska,
Simona Dostalova, Vedran Milosavljevic, Pavel Kopel,
Tomas Vaculovic, Sona Krizkova, Marketa Vaculovicova,
Vojtech Adam and Rene Kizek.
This original research article was viewed more than 800
times in the two months since being published online.
On the other hand, the most downloaded paper of 2015 is
another original research article titled:
Influence of Growth Parameters on the Formation of
Hydroxyapatite (HAp) Nanostructures and Their Cell
Viability Structures- by Murugesan Manoj, Ramesh
Subbiah, Devanesan Mangalaraj, Nagamony Ponpandian,
Chinnuswamy Viswanathan and Kwideok Park.
The journal looks forward to 2016
The journal looks forward to 2016 with new initiatives, by
increasing our efforts to reach out to academia and industry
to submit their manuscripts around nanobiomedicine
including, but not limited to the following areas; bioengin‐
eering, nano-technological applications in diagnostics,
therapeutic application, vaccine, drug discovery/delivery
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and regenerative medicine. Also, given President Obama’s
call for $215 million in 2016 to support his Precision
Medicine Initiative, this will enable a new era of medicine
in which researchers, providers and patients will work
together to develop individualized care. Precision medi‐
cine is an emerging approach for disease treatment and
prevention, which exams each individual based on their
variability in genes, environment, and lifestyle. $130
million of the allocated budget will be allocated to NIH to
build a national, large-scale research participant group,
called a cohort, and $70 million will be allocated to the
National Cancer Institute to lead efforts in cancer genomics.
There are many similar precision medicine initiatives
globally and given the field of nanobiomedicine, there are
many opportunities in the area diagnostics, therapeutics
and monitoring the response to therapy. So as a result of
these ongoing initiatives, we will seek to partner with
conference organizers not only in technical and application,
but to the precision medicine topics, to play a role as their
media partner, to publish abstracts and selected papers
presented at their conferences.
Lastly, we have been actively engaged with the BioPharma
Research Council (a partnership established last year) to co-
host webinars related to the journal on a variety of topics
and allow the presenter(s) to convert their presentation into
a manuscript as part of a BioPharma Research Council/
Nanobiomedicine webinar series. One initiative in the
process of being scheduled for April 2016 is a virtual
conference around the theme of Point of Care Diagnostics.
A committee with members from industry, including
Thomas White, retired Chief Scientific Officer from Celera
and, Joe Almeida from Siemens Healthcare have outlined
a framework of relevant topics (lab-on-a-chip for sample
preparation, detection systems including instruments and
reagents, therapeutic applications to implementation
(validation) and adoption) to be discussed during the one
day (from 5-8 speakers) virtual conference.
Volume 3 open for submissions on an ongoing basis
NBM accepts original and review articles as well as
editorials, perspectives, short research reports, protocols
and methods, notes to the editor, letters to the editor and
meeting dispatch reports. The NBM manuscript processing
and peer-review is entirely online. The Editorial Manager
facilitates the manuscript processing time, reducing costs
and is a better experience for our authors and reviewers.
We have received numerous positive comments on this
evolving electronic system, and we are indebted to InTech
for managing this program for us. For more information,
please visit our new manuscript submission system at
http://www.intechopen.com/journals/show/nanobiomedi‐
cine/submit-your-paper. In addition, we are enforcing to
expedite the acceptance to publishing time for our authors
and will request informal opinions from our Editorial
Board for borderline cases.
We would like to mention, InTech Open Access Publisher
has decided that NBM will not apply any article processing
charges for authors whose research papers have been
accepted for publication in Volume 3/2016. Finally, we
would like to thank InTech for supporting the initiatives of
this journal and acknowledge Petra Nenadic and her team
for her continuous and endless support, passion and
dedication for making this possible. In addition, we would
like to thank our highly renowned and respected Associate
Editors and Editorial Board members from all over the
world, whose expertise range from nano-fluidic systems to
nano-scale drug delivery to nano-imaging that are bridge
and a catalyst in their respective fields of nanotechnology
and biomedical research.
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